Guhan Pharmaceutical Group Co., Ltd. (SHE:000590)

China · Delayed Price · Currency is CNY

8.99

-0.70 (-7.22%)

Aug 21, 2026, 12:54 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceutical and Health Product Manufacturing and Sales Business	523.14M	-	-	-	-
Active Pharmaceutical Ingredient (API) Manufacturing and Sales Business	3.73M	-	-	-	-
Other Operations	17.63M	-	-	-	2.29M
Offset of Business Segment	-206.82M	-	-	-	-
Production and Sales of Western Medicine	-	-	-	-	13.63M
Production and Sales of Traditional Chinese Medicine	-	-	-	-	284.86M
Medicine Manufacturing	-	-	384.66M	346.53M	-
Unallocated Others	-	-	19.98M	4.00M	-
Total	337.67M	-	404.65M	350.53M	300.77M

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China	337.67M	343.21M	404.65M	350.53M	300.77M
Total	337.67M	343.21M	404.65M	350.53M	300.77M